CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

There have been promising results from clinical trials on the efficacy of engineering patients’ immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.

Detalles Bibliográficos
Autores principales: Stadtmauer, Edward, Mangan, Patricia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003752/
https://www.ncbi.nlm.nih.gov/pubmed/29928544

Ejemplares similares

Ejemplares similares